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Abstract
Background:  NOD2 is an innate immune receptor for the bacterial cell wall component
muramyl-dipeptide. Mutations in the leucine-ric h  r e p e a t  r e g i o n  o f  N O D 2 ,  w h i c h  l e a d  t o  a n
impaired recognition of muramyl-dipeptide, have been associated with Crohn disease, a human
chronic inflammatory bowel disease. Tissue specific constitutive and inducible expression patterns
of NOD2 have been described that result from complex regulatory events for which the molecular
mechanisms are not yet fully understood.
Results: We have identified two novel exons of the NOD2 gene (designated exon 1a and 1b),
which are spliced to the canonical exon 2 and constitute the 5' untranslated region of two
alternative transcript isoforms (i.e. exon 1a/1b/2 and exon 1a/2). The two novel transcripts are
abundantly expressed and seem to comprise the majority of NOD2 transcripts under physiological
conditions. We confirm the expression of the previously known canonical first exon (designated
exon 1c) of the gene in unstimulated mononuclear cells. The inclusion of the second alternative
exon 1b, which harbours three short upstream open reading frames (uORFs), is downregulated
upon stimulation with TNF-α or under pro-inflammatory conditions in the inflamed intestinal
mucosa in vivo. Using the different 5' UTR splice forms fused to a firefly luciferase (LUC) reporter
we demonstrate a rapamycin-sensitive inhibitory effect of the uORFs on translation efficacy.
Conclusion: The differential usage of two alternative promoters in the NOD2 gene leads to tissue-
specific and context-dependent NOD2 transcript isoform patterns. We demonstrate for the first
time that context-dependent alternative splicing is linked to uORF-mediated translational
repression. The results suggest complex parallel control mechanisms that independently regulate
NOD2 expression in the context of inflammatory signaling.
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Background
NOD2 (CARD15, NLRC2) is a member of the family of
the NACHT/LRR receptors, which are characterized by a
central nucleotide-binding and oligomerization domain
and a C-terminal sensor domain consisting of repeats of
leucine-rich repeats (LRR) [1,2]. The LRRs of NOD2 have
been described to directly or indirectly recognize intracel-
lular muramyl-dipeptide (MDP), an abundant cell wall
component of both gram-negative and gram-positive bac-
teria [3,4]. The recognition of MDP leads to a recruitment
of the protein kinase RIP2/RICK to the N-terminal effector
binding domain, which consists of two adjacent caspase-
recruitment domains (CARDs). Subsequently, the canon-
ical IKK/IκB/NF-κB pathway is activated via induced prox-
imity signaling [5]. NOD2 has been identified as the first
major susceptibility gene for Crohn's disease (CD) [6-8].
Three genomic variations within the NOD2  gene, one
frameshift (rs2066847, L1007fsinsC) and two missense
mutations (rs2066845  – G908R, rs2066844  – R702W)
represent the main causative functional variants and are
associated with a deficient activation of the transcription
factor nuclear factor-kappa B (NF-κB) upon microbial
triggering [6-10]. It has recently been shown that pro-
inflammatory stimuli, such as TNF-α, IFN-γ and lipopoly-
saccharide (LPS) activate NOD2 (CARD15) gene expres-
sion in intestinal epithelial cell lines and primary
intestinal epithelial cells as well as monocytic HL-60 cells
[11,12]. This up-regulation is at least in part dependent on
the binding of NF-κB to a proximal κB-binding element (-
26) of a NOD2 promoter region in front of the canonical
first exon.
While performing the mutation detection and gene model
verification of NOD2/CARD15, we performed cross-spe-
cies comparisons and EST database analyses that indi-
cated an incomplete annotation of the 5' region of the
gene. We have thus investigated the genomic region of the
NOD2 (CARD15) locus for the evidence of additional
upstream exons. We show that two additional untrans-
lated exons exist located upstream of previously described
first exon of the NOD2 (CARD15) gene, which are present
in transcript isoforms that exclude the previously reported
canonical exon 1. These two exons exhibit a distinct splic-
ing pattern under pro-inflammatory conditions both in
vitro  (monocytic cells) and in colonic biopsies from
patients with chronic inflammatory bowel disease (IBD)
in vivo. A long isoform, which contains both novel exons,
contains three short upstream open reading frames
(uORFs), which are shown to inhibit translational efficacy
of the respective transcript. The results provide evidence
for a complex regulation of NOD2 expression that
includes the alternative usage of two promoters and post-
transcriptional regulation of translation by uORFs.
Results
Database and inter-species comparisons of the NLR family
Database sequences and cross-species comparisons indi-
cated that the current annotation of the 5' – part of the
NOD2/CARD15  transcript is incomplete: The CARD15
gene structure as annotated in the Genbank record
AF178930 was comprised of 12 exons with the transla-
tional start in exon 1 and the stop codon in exon 12. The
Northern analysis as reported by Ogura showed two tran-
scripts in peripheral blood leukocytes [5]. Furthermore,
CARD15 mRNA isoforms in the databases differ in their 5'
part and in the number of exons (AF178930[5]; AJ303140
[6]).
A comparison of the 5'UTRs of the CARD15 mRNA spe-
cies and those of the other members of the NOD family,
APAF-1 and CARD4 (NOD1) indicated striking differ-
ences. Both APAF-1 (577 nt) and CARD4 (424 nt) tran-
scripts exhibit much longer 5'UTRs as compared to 105 or
146 nucleotides in the deposited CARD15 mRNAs.
Inspection of the genomic locus of CARD15 revealed
another discrepancy in the locus organization of
CARD15. While the first exons of APAF-1 and CARD4 are
located in CpG islands and their positions are predicted at
the respective genomic loci by a commonly used pro-
moter/first exon prediction program, the 5' end of the
CARD15 gene is not found in such a context. The gene
structures of CARD4 and CARD15 indicate that the two
genes are paralogues, because their exon/intron architec-
ture is very similar with respect to both exon sizes as well
as intron phases. This similarity is not present in the 5'
parts of the genes.
An interspecies comparison of the human
(NM_022162.1) and murine (NM_145857.2) and bovine
(NM_001002889.1) transcripts of CARD15 shows a lack
of homology upstream of exon 2 (Suppl. Fig 1).
Additional upstream exons of the CARD15 gene
We scanned 13 kb upstream of exon 2 with the FirstEF
program [13]. The program detected no CpG island in
front of the previously described exon 1. The prediction
program detected a promoter and first exon within a CpG
island about 3.5 kb upstream of exon 1 of the CARD15
locus. RT-PCR with primers located in this predicted exon
and in the known exon 2 was performed. Two amplicons
were obtained from cDNA of peripheral blood leukocytes
(Figure 1A). Cloning and sequencing revealed that the
smaller species corresponds to the predicted first exon
spliced to exon 2 of CARD15. The larger amplicon con-
tained an additional exon included between the new exon
1 and exon 2, which corresponded to an exon predicted to
belong to an independent grailed-homology transcript [6].
Canonical splice sites are flanking the intervening
sequences on the genomic DNA (Figure 1B). We nameBMC Genomics 2007, 8:472 http://www.biomedcentral.com/1471-2164/8/472
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Structure of the 5'region of the human NOD2 gene and expression of transcript isoforms Figure 1
Structure of the 5'region of the human NOD2 gene and expression of transcript isoforms. (A) Sequence of the 
novel two exons in the genomic context. Exons are capitalized, ATGs representing upstream ORFs are in bold print. The pro-
ductive ATG used as an alternative translation start in exon 2 is marked by an asterisk. (B) Graphical representation of the 
alternatively spliced isoforms from the two alternate promoters. STP, stop codon of the uORFs. Below is a representation of 
the alternatively translated protein isoforms depicted by single letter amino acid code. (1) denotes the original start in the 
canonical exon 1, (2) denotes the alternative start in exon 2 used by the two novel transcript isoforms. (C) Primary monocytes 
were treated with TNF-α (10 ng/ml) for 12 h. NOD2 was amplified as outlined and analyzed on agarose gels (D) Amplification 
of NOD2 in a human multiple tissue panel. Note the preponderance of the short isoform exon1a/2 in the leukocytes. (E) Den-
sitometric analysis of RT-PCR experiments from colonic biopsies of healthy controls and inflamed tissue from Crohn disease 
patients. Depicted is the ratio between the short (exon1a/2) and the long (exon 1a/1b/2) isoform of NOD2 (**p < 0.002; *p < 
0.05, Student's T-test, colonic samples from n = 8 healthy controls and n = 11 inflamed Crohn disease patients;n = 5 ileal sam-
ples from healthy controls and n = 5 inflamed ileal samples from Crohn disease patients).BMC Genomics 2007, 8:472 http://www.biomedcentral.com/1471-2164/8/472
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these newly identified exons 1a and 1b and keep the des-
ignation (exon1) for the formerly described first exon (as
in AF178930). These exons were also confirmed by
5'rapid amplification of cDNA ends (RACE) using a gene
specific reverse primer in exon 2 and sequences were
deposited in the NCBI database (AY187245, short alterna-
tive 5'UTR; AY187242, long alternative 5'UTR; AY187243,
canonical exon1). The short alternative 5'UTR has also
been found in a systematic approach characterizing tran-
scripts, which contain alternative promoter regions
(DA224866 in [14]).
RT-PCR using sense as well as antisense primers located in
exon 1 in combinations with the respective forward and
reverse primers in exon 1a and 1b did not detect an ampli-
con containing exon 1c together with the novel exons in
cDNA derived from human monocytes and in cDNAs
from various organs (heart, brain, placenta, lung, liver,
skeletal muscle, kidney, pancreas, spleen, thymus, pros-
tate, testis, ovary, small intestine and colon) (data not
shown). PCR amplification with primers located in exon
1c gave a positive result when using reverse primers in
exon 2, 3 or 4. The results taken together with other find-
ings that confirm the existence and/or induction of the
canonical exon 1 [5,11,15] point to the usage of two alter-
native promoters.
Distribution and regulation of splice isoforms
To identify expression patterns of the alternative transcript
isoforms, we analyzed expression in adult human tissues
by RT-PCR methods using primers spanning exon1a to 4.
The identity of the resulting amplicons was confirmed by
DNA sequencing (not shown). The RT-PCR analysis
showed that the mRNA for the alternative NOD2 isoforms
are abundantly expressed in the small intestine, colon,
prostate, lung and in liver. Interestingly, the ratio between
the long and the short isoform varied considerably, e.g.
peripheral blood leukocytes showed a striking preponder-
ance of the short exon 1a/2 isoform (alt 5'UTR NOD2 a,
Fig. 1D).
To analyze whether the ratio of the different UTR mRNA
isoforms of NOD2 is regulated by cytokine stimulation,
primary human monocytes were purified and stimulated
for 12 h with TNF-α (10 ng/ml). Transcripts encoding
novel isoforms of NOD2 were amplified as outlined and
analyzed on an agarose gel (Fig. 1C). Here, the stimula-
tion of resting monocytes led to a decrease of the long
(exon1a/1b/2; alt 5'UTR NOD2 b) isoform to nearly
undetectable levels, whereas the levels of transcripts
encoding the alternative short form were increased. The
transcript ratio of the UTR isoforms of NOD2 upon stim-
ulation was further analyzed by cloning and counting of
PCR products (> 100 individual clones) as previously
described [16,17]. The percentage of clones containing
the short form of the UTR was similarly increased upon
TNF-α stimulation (data not shown).
A pronounced increase of the short UTR isoform was
detectable in inflamed colonic and ileal biopsy specimen
from patients with Crohn disease. Using a densitometric
analysis of agarose gels of colonic samples, the short form
(exon1a/2) was significantly overrepresented in inflamed
CD biopsies, whereas in control subjects, which under-
went colonoscopy for routine cancer surveillance, four to
five times more of the long isoform (exon 1a/1b/2) was
detected (Fig 1E, p < 0.002, Student's T-test). In contrast,
in non-inflamed biopsies from healthy controls higher
levels of the short form (exon1a/2) were observed than in
the non-inflamed colonic samples. However, in inflamed
ileal biopsies of Crohn disease patients only the short
form (exon 1a/2) was detectable (Fig. 1E, p < 0.05).
Upstream ATGs in exon 1b inhibit translation efficiency
Sequence inspection suggested that the NOD2 mRNA iso-
form with exon1a being joined directly to exon 2 (alt
5'UTR NOD2 a) allows translation from the very first ATG
localized in exon 2. The longer isoform (Exon1a/1b/2, alt
5'UTR NOD2 b) appeared to exhibit structural features
which may interfere with efficient translation. Exon 1b
contains three additional upstream ATGs (uATGs), the
first two being in the same phase with a stop codon and
the subsequent CARD15 start, while the third one begins
a new upstream ORF (uORF) in a different reading frame.
No significant similarity to other known proteins was
found in the 14 amino acid peptide (MGLTLGRTMVS-
LKL) resulting from the first uORF in the non-redundant
(nr) sequence database using blastp and blastx algo-
rithms. The second uORF encodes a six amino acid (MVS-
LKL) peptide, the third start methionie results in an uORF
of 4 amino acids (MQID). uATGs and short uORFs are
considered as regulatory elements for expression control
on the level of translation. We inserted the UTRs upstream
of the exon 2 ATG of the two newly identified splice forms
into a reporter gene vector in order to monitor differential
translation efficiency by dual luciferase assays (Figure 2A).
HEK 293 cells and HL-60 monocytic cells (not shown)
transfected with the short form (alt 5'UTR NOD2 a)
exhibit up to 4-fold higher luciferase activities than cells
transfected with the vector containing the longer isoform
(alt 5'UTR NOD2 b; Figure 2B). Using sequential deletion
constructs of the three uATGs (∆ATG 1–3) generated by
site-directed mutagenesis we could demonstrate that the
translation effiency from the same construct was signifi-
cantly increased when the uORFs were removed (Figure
2C). Similarly, treatment of alt 5'UTR NOD2 b-Luc trans-
fected cells with the mTOR inhibitor rapamycin led to an
increase of luciferase activity (Figure 3) suggesting a role
for an mTOR mediated modulation of the translation ini-
tiation factors eIF2 α and eIF4E in the control of theBMC Genomics 2007, 8:472 http://www.biomedcentral.com/1471-2164/8/472
Page 5 of 9
(page number not for citation purposes)
Upstream ORFs (uORFs) in the 5'UTR of the alternative NOD2 transcripts have an effect on translational efficacy Figure 2
Upstream ORFs (uORFs) in the 5'UTR of the alternative NOD2 transcripts have an effect on translational effi-
cacy. (A) Reporter gene constructs containing the differentially spliced alternative 5'UTRs of NOD2 (alt 5' UTR NOD2 a, con-
taining only exon 1a and alt 5' UTR NOD2 b containing exon 1a and 1b) cloned in front of a luciferase reporter gene (pGL 
Basic) ATG1-3 denote the uAUGs and STP the respective stop codons. (B) Constitutive luciferase activities of the two con-
structs in transfected HEK293 cells. (C) Sequential deletion of the uAUGs (e.g. ∆ATG 1 denotes deletion of the first uAUG) 
abolishes the inhibitory activity of the long alternative 5'UTR (alt 5' UTR NOD2 b). All values correspond to mean ± SD calcu-
lated from at least three independent experiments. RLU, relative luciferase units, determined by dual luciferase assay *p < 0.05, 
**p < 0.01, Student's T-Test).BMC Genomics 2007, 8:472 http://www.biomedcentral.com/1471-2164/8/472
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uORF-mediated translational repression of NOD2 as
reported for other uORF-containing UTRs [18-22].
Discussion and Conclusion
The salient finding of the present study is the demonstra-
tion of two novel exons (exon1a and 1b) in the NOD2/
CARD15 gene, which appear to contribute to the tight reg-
ulation of NOD2 protein levels in the physiological set-
ting. Expression of transcripts containing exon1a and 1b
is driven by an alternative promoter located within a CpG
island, whereas transcripts containing the canonical exon
1 are regulated by an NF-κB-dependent promoter. Evi-
dence is increasing that the 5'-UTR of eukaryotic mRNA
pivotally contributes to post-transcriptional regulation of
gene expression [23-26]. AUG codons (uAUG) upstream
of the main open reading frame or short upstream ORFs
are present in approx. 10% of all mRNAs [27]. Although
the functional impact of this mechanism has not been
investigated on a genome-wide level, recent studies on
selected UTRs containing uAUGs or uORFs suggest an
important role in negative translational control across
kingdoms from plants to mammals [28-32]. Within the
exon 1b of the alternative 5'-UTR region of human NOD2,
three uORFs with variable lengths were identified
upstream of the main ORF located in exon 2. These uORFs
exert a negative influence on translational efficacy as
shown by luciferase reporter gene assays and site-directed
mutagenesis of the uAUGs. The effect was rapamycin-sen-
sitive pointing to a role of the eukaryotic translation initi-
ation factors eIF2α and eIF4E, which were shown to be
decisive factors for regulated initiation of translation of a
subset of mRNAs that have cis-regulatory small upstream
open reading frames [18,22,33]. Although a tendency
towards higher luciferase expression was observed for the
reporter construct representing the short novel isoform
after stimulation with the proinflammatory cytokine TNF-
α, further investigations are warranted to identify signal-
ing pathways involved in adjusting the activity of elFs in
acute and chronic inflammation.
We demonstrate for the first time that context-dependent
alternative splicing is linked to uORF-mediated transla-
tional repression. This additional regulatory mechanism
may to contribute to the overall control of NOD2 protein
level in inflammation. We show that stimulation of
monocytic cells with the pro-inflammatory cytokine TNF-
α shifts the ratio of the splice isoforms towards the shorter
isoform that lacks exon1b containing the regulatory
uORFs. Similarly, in the inflamed colonic tissue of Crohn
disease patients, a preponderance of the short alternative
5'UTR transcript isoform could be detected, which may
result in higher protein levels in the absence of uORFs.
The three main variants in NOD2  (rs2066847  –
L1007fsinsC,  rs2066845  – G908R and rs2066844  –
R702W) are genetically associated with a distinct subphe-
notype of CD involving the small intestine (Vienna Clas-
sification L1 and L3 [34]) [35,36]. High constitutive
expression of NOD2 has been shown in Paneth cells [37],
which represent specialized IECs secreting antimicrobial
peptides in the terminal ileum. A genetic ablation of Nod2
in mice leads to a distinct defect in cryptdin (α-defensin
orthologues in mice) expression in the ileum [38]. Con-
sistently, a NOD2-genotype dependent impairment of
human  α-defensin -5 and -6 has been shown in ileal
CD[39], which may pivotally contribute to the immuno-
logical barrier dysfunction observed in CD etiopathogen-
esis [40]. Interestingly, in biopsies from the ileum we
observed a higher constitutive representatation of the
short (i.e. translationally more active exon 1a/2) isoform.
In the inflamed ileum only the exon1a/2 form was detect-
able. We thus hypothesize that alternative splicing of the
two novel isoforms contributes to the upregulation of
NOD2 protein levels observed under inflammatory con-
ditions and the high constitutive expression in distinct cell
types, i.e. monocytic cells and, possibly, Paneth cells.
Interestingly, stimulation of monocytes with TNF-α
results in a downregulation of a short alternatively spliced
isoform of NOD2 encoding an auto-inhibitory CARD-
only protein, which is generated by skipping of exon 3
[17]. Albeit reciprocal mechanisms involved (increased
vs. decreased exon skipping), these complex changes in
splice patterns of NOD2 transcripts after TNF-α stimula-
Translational inhibition of the alternative NOD2 5'UTR can  be inhibited by rapamycin Figure 3
Translational inhibition of the alternative NOD2 
5'UTR can be inhibited by rapamycin. Relative luci-
ferase activities were determined from the construct con-
taining both 5'UTR exons with and without deletion of the 
uAUGs (∆ATG1.2.3 and wildtype). Note the significant 
reduction of the inhibitory effect of the uORFs after rapamy-
cin treatment (1 µM). Values represent mean ± SD calculated 
from three independent experiments. RLU, relative luciferase 
units, determined by dual luciferase assay *p < 0.05, Student's 
T-Test).BMC Genomics 2007, 8:472 http://www.biomedcentral.com/1471-2164/8/472
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tion all result in a higher sensitivity of the cellular NOD2
sensor function.
An obvious paradoxon is created by the fact that "loss-of
function" variants in NOD2 have been genetically associ-
ated with a higher risk for the development of Crohn dis-
ease, whereas higher levels of NOD2 protein have been
detected by several groups independent from the respec-
tive NOD2 genotype. However, it is generally accepted
that up-regulation of NOD2 expression in intestinal
inflammation is a generic response to bacterial invasion
and represents a futile attempt to restore the disrupted
epithelial barrier in patients with Crohn disease. It will be
a major goal to dissect the contribution of the differential
usage of the two alternative promoters in different cell
types and the regulation of the uORF-mediated transla-
tional repression to the overall control of NOD2 protein
level. These studies may not only provide deeper insights
in the pathophysiology of human inflammatory disor-
ders, but may also help to understand the complex physi-
ological regulation of sensitivity and tolerance of the
innate immune system during the life-long interaction
with the commensal flora.
Methods
Exploration of the 5' region: computer analyses, RT-PCR
The genomic sequence of the CARD15 locus (Genbank:
AF178930) was analyzed using computer prediction
methods as described in [13]. In order to verify the pub-
lished NOD2 gene model, conserved exons were searched
for in mouse, cow and human genomic sequences (Twin-
scan gene predictions [41]) and related to predicted splice
sites [42]. 5'exons of the different species were aligned
using ClustalW [43]. The previously reported and the pre-
dicted exons were verified by RT-PCR and by subsequent
cloning and sequencing of PCR products: (i) in a pool of
cDNA tissue samples, (ii) in cDNA derived from freshly
isolated monocytes and (iii) in cDNA from colonic biop-
sies.
Monocyte isolation & colonic biopsy samples
Monocytes were isolated from 100 ml of peripheral blood
drawn from four healthy volunteers (age range 24 – 33; 1
female) and cultured as described previously [44]. CD
Patients (n = 11 for colonic biopsies, n = 5 for ileal biop-
sies) and normal controls (n = 8 for colonic biopsies and
n = 5 for ileal biopsies) were recruited at the Department
of General Internal Medicine in Kiel, Germany. Up to six
additional biopsies were obtained from inflamed regions
as part of a routine colonoscopy indicated on clinical
grounds. The diagnosis of Crohn's disease was assigned
on the basis of established clinical, endoscopic and radio-
logical findings. Normal control biopsies were obtained
from patients, who had a macroscopically and histologi-
cally normal colon, during procedures performed for the
investigation of unspecific abdominal pain or cancer
screening. All individuals gave written, informed consent
for extra biopsies and/or anonymized genetic and func-
tional analysis at least one day before the procedure. The
study and sample collection was approved by the institu-
tional ethics board before initiation of the study.
Biopsies were snap frozen in liquid nitrogen immediately
after sampling. Snap-frozen biopsies were crushed to a
fine powder under liquid nitrogen using a manual crusher
with a teflon head (Omnilab, Bremen/Germany) and
total RNA was isolated using the RNeasy Mini Kit (Qia-
gen, Hilden/Germany) according to the manufacturers
protocol. Eluted RNA was determined to be intact as
assessed by standard formamide gel electrophoresis and
shown to be free of contaminating genomic DNA when
primers specific for GAPDH yielded a PCR product only
after reverse transcription.
mRNA isolation and RT-PCR
Total RNA from primary peripheral blood monocytes was
isolated using the RNeasy kit from Qiagen. 300 ng of total
RNA were reverse transcribed as described elsewhere [44].
For investigation of tissue specific expression patterns, a
commercial tissue panel was obtained from Clontech
(Palo Alto, CA, USA). Primers used for amplification of
the alternative NOD2 transcript were (5'-CAC TGG GCT
TTT GGC GTT C-3' (sense) and 5'-CGG CAA CCT GAT
TTC ATC AC-3' (antisense). Primers used for amplifying
the canonical transcript were 5'-GGA GTG GGC CTT GGA
GTC GG-3' (sense) and 5'-CCA GGA CAT TCT CTG TGT
ATA T-3' (antisense).
The following conditions were applied: Denaturation for
5 min at 95°C; 35 cycles of 30 sec at 95°C, 20 sec at 60°C,
45 sec at 72°C; final extension for 10 min at 72°C. To
confirm the use of equal amounts of RNA in each experi-
ment all samples were checked in parallel for β-actin
mRNA expression. All amplified DNA fragments were
analyzed on 1% agarose gels and subsequently docu-
mented by a BioDoc Analyzer (Biometra, Göttingen, Ger-
many).
Quantification of splice variants
To determine the exact ratio of transcripts containing
exon1a/1b/2 vs. exon 1a/2, we employed a clone sequenc-
ing method that has been described to unveil genotype-
splicing effects [11,16,45]. PCR products from 30 rounds
of PCR (exponential phase) were ligated into a TA-cloning
vector (Invitrogen) and the indicated numbers of individ-
ual clones were sequenced using Dye terminator chemis-
try (Applied Biosystems, Foster City, CA, USA) on a 3730
× L DNA Analyzer (Applied Biosystems).BMC Genomics 2007, 8:472 http://www.biomedcentral.com/1471-2164/8/472
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Reporter assays
The 5'ÚTR of the alternative NOD2 transcript was ampli-
fied from cDNA by PCR under standard conditions with
the following primers (restriction sites underlined)
NOD2HindIIIpGL: AAGCTTGGAGTGGGCCTTGGAGTC
und NOD2NcoIpGL: CCATGGACATTTCACAACCT-
GGTCG and cloned into a TA vector (Invitrogen). After
HindIII/NcoI restriction the inserts were subcloned into a
pGL2-luciferase plasmid (Promega). All constructs were
sequence-verified in an ABI3730xL sequencer prior to use.
Modifications of the UTR were performed with the site-
directed mutagenesis kit from Stratagene according to the
manufacturer's instructions. All primers were purchased
from Eurogentec (Liège, Belgium).
HL-60 myelomonocytic and HEK293 cells were pur-
chased from the German Collection of Microorganisms
and Cell Cultures (DSMZ, Braunschweig, Germany). All
cells were cultured in RPMI + 10% fetal calf serum (FCS).
Transfections were performed with Fugene 6™ (Roche,
Basel, Switzerland) using indicated amounts of the respec-
tive plasmids. Medium was changed 4 h after the transfec-
tion to avoid transfection reagent presence at the time of
stimulation. TNF-α was purchased from R&D Systems
(MN, USA), rapamycin was from Sigma (Deisenhofen,
Germany). Normalized luciferase activity was determined
with a Dual Luciferase Reporter gene kit (DLR) from
Promega using the the Renilla-containing plasmid pRL-TK
driven by the thymidin kinase minimal promoter. Cell
lysates were analyzed with a Tecan Genios Pro (Tecan,
Bubendorf, Switzerland). All samples were at least meas-
ured in duplicates and are results of three independent
experiments. The results for firefly luciferase activity were
normalized to renilla luciferase activity.
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